Kauffman Michael
Insider CIK 1364719 · INFI Director · ZLCS Director · KPTI President, CEO & CMO, Director · VSTM President of Development, Director · KZR Director · ACET Director · FGEN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYNB KYNTRA BIO, INC. | A Award deriv | 2026-06-12 | 2026-06-17 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 5,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 3,500 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 389 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 889 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 889 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 2,600 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2026-05-11 | 2026-05-11 | 2,600 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | U Tender | 2026-05-11 | 2026-05-11 | 6,369 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2026-01-06 | 2026-01-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VSTM Verastem, Inc. | S Sale | 2025-11-21 | 2025-11-25 | 8,550 | $10.00 | $85.5K | 8,666 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2025-06-18 | 2025-06-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2025-06-04 | 2025-06-06 | 120,000 | — | $0 | 120,000 | SEC↗ |
| FGEN FIBROGEN INC | A Award deriv | 2025-06-04 | 2025-06-06 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2025-05-22 | 2025-05-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2025-05-22 | 2025-05-27 | 8,333 | — | $0 | 17,216 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 37,000 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2024-08-21 | 2024-08-23 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-08-21 | 2024-08-23 | 37,000 | — | $0 | 37,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2024-06-18 | 2024-06-20 | 8,333 | — | $0 | 8,883 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2024-06-05 | 2024-06-07 | 5,900 | — | $0 | 11,800 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2024-06-05 | 2024-06-07 | 5,900 | $1.43 | $8.4K | 5,900 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-03-11 | 2024-03-13 | 16,078 | — | $0 | 16,078 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 1,497 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 37,000 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-08-14 | 2023-08-16 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACET Adicet Bio, Inc. | D To issuer deriv | 2023-08-14 | 2023-08-16 | 26,400 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 26,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 8,896 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 8,896 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2023-06-01 | 2023-06-02 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2023-06-01 | 2023-06-02 | 5,900 | — | $0 | 5,900 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2023-05-15 | 2023-05-16 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 62,500 | — | $0 | 62,500 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 26,000 | — | $0 | 26,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2022-06-02 | 2022-06-03 | 18,500 | — | $0 | 18,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-05-12 | 2022-12-20 | 62,500 | — | $0 | 62,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-02-28 | 2022-03-02 | 27,000 | — | $0 | 27,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2022-02-28 | 2022-03-02 | 21,000 | — | $0 | 719,983 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-28 | 2022-03-02 | 6,226 | $10.24 | $63.8K | 898,131 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-28 | 2022-03-02 | 6,226 | $10.24 | $63.8K | 713,757 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-17 | 2022-02-22 | 9,079 | $12.12 | $110.0K | 698,983 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-17 | 2022-02-22 | 9,088 | $12.12 | $110.1K | 904,357 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-07 | 2022-02-09 | 6,764 | $9.86 | $66.7K | 708,062 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-07 | 2022-02-09 | 6,707 | $9.86 | $66.1K | 913,445 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 3,896 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 5,000 | $16.45 | $82.3K | 63,690 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | M Exercise | 2022-01-03 | 2022-01-05 | 5,000 | $5.91 | $29.6K | 68,690 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2021-11-17 | 2021-11-18 | 37,000 | — | $0 | 37,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-03-18 | 2021-03-23 | 4,000 | $12.39 | $49.6K | 714,826 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-02-25 | 2021-03-01 | 153,500 | — | $0 | 153,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-02-25 | 2021-03-01 | 153,500 | — | $0 | 153,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-02-25 | 2021-03-01 | 57,200 | — | $0 | 718,826 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-02-25 | 2021-03-01 | 57,200 | — | $0 | 920,152 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-18 | 2021-02-22 | 9,495 | $14.83 | $140.8K | 575,126 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-18 | 2021-02-22 | 9,495 | $14.83 | $140.8K | 776,452 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-15 | 2021-02-17 | 21,800 | — | $0 | 43,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-15 | 2021-02-17 | 21,800 | — | $0 | 43,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-15 | 2021-02-17 | 21,800 | — | $0 | 584,621 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-15 | 2021-02-17 | 21,800 | — | $0 | 785,947 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-11 | 2021-02-17 | 6,642 | $15.52 | $103.1K | 764,147 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-11 | 2021-02-17 | 6,601 | $15.52 | $102.4K | 562,821 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-05 | 2021-02-09 | 14,300 | — | $0 | 42,900 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-05 | 2021-02-09 | 14,300 | — | $0 | 42,900 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-05 | 2021-02-09 | 14,300 | — | $0 | 770,789 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-05 | 2021-02-09 | 14,300 | — | $0 | 569,422 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-10-12 | 2020-10-14 | 6,076 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-10-12 | 2020-10-14 | 1,424 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-10-12 | 2020-10-14 | 1,424 | $0.03 | $43 | 757,913 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-10-12 | 2020-10-14 | 7,500 | $14.89 | $111.7K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-10-12 | 2020-10-14 | 6,076 | $0.03 | $182 | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-08-17 | 2020-08-18 | 1,477 | — | $0 | 6,076 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-08-17 | 2020-08-18 | 1,477 | $15.00 | $22.2K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-08-17 | 2020-08-18 | 1,477 | $0.03 | $44 | 757,966 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-07-15 | 2020-07-17 | 7,500 | — | $0 | 1,424 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-07-15 | 2020-07-17 | 7,500 | $19.43 | $145.7K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-07-15 | 2020-07-17 | 7,500 | $0.03 | $225 | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-07-10 | 2020-07-13 | 7,500 | — | $0 | 333,561 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-07-10 | 2020-07-13 | 7,500 | $4.75 | $35.6K | 562,622 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-07-10 | 2020-07-13 | 7,200 | $18.98 | $136.7K | 555,422 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-07-10 | 2020-07-13 | 300 | $19.71 | $5.9K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-07-09 | 2020-07-13 | 7,500 | — | $0 | 377,803 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-07-09 | 2020-07-13 | 7,500 | $4.75 | $35.6K | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-07-09 | 2020-07-13 | 7,500 | $19.53 | $146.5K | 756,489 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 8,896 | — | $0 | 8,896 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-06-22 | 2020-06-24 | 7,500 | — | $0 | 8,924 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-06-22 | 2020-06-24 | 7,500 | $0.03 | $225 | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-06-22 | 2020-06-24 | 7,500 | $20.00 | $150.0K | 756,489 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-06-15 | 2020-06-17 | 357 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-06-15 | 2020-06-17 | 7,143 | — | $0 | 16,424 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-06-15 | 2020-06-17 | 7,143 | $0.03 | $214 | 763,632 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-06-15 | 2020-06-17 | 357 | $16.20 | $5.8K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-06-15 | 2020-06-17 | 7,143 | $16.38 | $117.0K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-06-15 | 2020-06-17 | 357 | $0.03 | $11 | 756,846 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-06-10 | 2020-06-11 | 7,500 | — | $0 | 341,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-06-10 | 2020-06-11 | 7,500 | $18.13 | $136.0K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-06-10 | 2020-06-11 | 7,500 | $4.75 | $35.6K | 562,622 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-06-09 | 2020-06-11 | 7,500 | — | $0 | 385,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-06-09 | 2020-06-11 | 7,500 | $18.50 | $138.8K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-06-09 | 2020-06-11 | 7,500 | $4.75 | $35.6K | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-05-18 | 2020-05-19 | 7,500 | — | $0 | 357 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-05-18 | 2020-05-19 | 7,500 | $0.03 | $225 | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-18 | 2020-05-19 | 7,500 | $20.00 | $150.0K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-05-15 | 2020-05-19 | 7,500 | — | $0 | 7,857 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-05-15 | 2020-05-19 | 7,500 | $0.03 | $225 | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-15 | 2020-05-19 | 7,500 | $18.65 | $139.9K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-05-07 | 2020-05-11 | 7,500 | — | $0 | 392,803 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-05-07 | 2020-05-11 | 7,500 | — | $0 | 348,561 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-07 | 2020-05-11 | 7,500 | $19.63 | $147.2K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-05-07 | 2020-05-11 | 7,500 | $4.75 | $35.6K | 763,989 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-05-07 | 2020-05-11 | 7,500 | $4.75 | $35.6K | 562,622 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-07 | 2020-05-11 | 7,500 | $19.63 | $147.2K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-04-09 | 2020-04-10 | 10,000 | — | $0 | 356,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-04-09 | 2020-04-10 | 10,000 | $20.64 | $206.4K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-04-09 | 2020-04-10 | 10,000 | $4.75 | $47.5K | 565,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-04-08 | 2020-04-10 | 10,000 | — | $0 | 400,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-04-08 | 2020-04-10 | 10,000 | $4.75 | $47.5K | 766,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-04-08 | 2020-04-10 | 10,000 | $18.61 | $186.1K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-03-10 | 2020-03-11 | 10,000 | — | $0 | 366,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-10 | 2020-03-11 | 2,068 | $22.64 | $46.8K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-10 | 2020-03-11 | 7,932 | $22.11 | $175.4K | 557,190 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-03-10 | 2020-03-11 | 10,000 | $4.75 | $47.5K | 565,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-03-09 | 2020-03-11 | 10,000 | — | $0 | 410,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-03-09 | 2020-03-11 | 10,000 | $4.75 | $47.5K | 766,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-09 | 2020-03-11 | 7,000 | $22.58 | $158.1K | 759,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-09 | 2020-03-11 | 3,000 | $22.38 | $67.1K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-19 | 2020-02-21 | 8,817 | $16.48 | $145.3K | 555,122 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-19 | 2020-02-21 | 8,817 | $16.48 | $145.3K | 756,489 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-15 | 2020-02-19 | 21,800 | — | $0 | 65,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-15 | 2020-02-19 | 21,800 | — | $0 | 65,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-15 | 2020-02-19 | 21,800 | — | $0 | 563,939 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-15 | 2020-02-19 | 21,800 | — | $0 | 765,306 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-11 | 2020-02-12 | 10,000 | — | $0 | 376,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-11 | 2020-02-12 | 10,000 | $4.75 | $47.5K | 552,139 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-11 | 2020-02-12 | 10,000 | $17.43 | $174.3K | 542,139 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-10 | 2020-02-12 | 10,000 | — | $0 | 420,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-10 | 2020-02-12 | 10,000 | $4.75 | $47.5K | 753,506 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-10 | 2020-02-12 | 10,000 | $16.93 | $169.3K | 743,506 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 57,200 | — | $0 | 57,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 153,500 | — | $0 | 153,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 57,200 | — | $0 | 57,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 153,500 | — | $0 | 153,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-01-09 | 2020-01-10 | 10,000 | — | $0 | 386,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-01-09 | 2020-01-10 | 10,000 | $19.19 | $191.9K | 542,139 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-01-09 | 2020-01-10 | 10,000 | $4.75 | $47.5K | 552,139 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-01-08 | 2020-01-10 | 10,000 | — | $0 | 430,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-01-08 | 2020-01-10 | 10,000 | $18.57 | $185.7K | 743,506 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-01-08 | 2020-01-10 | 10,000 | $4.75 | $47.5K | 753,506 | SEC↗ |
| KPTI Karyopharm Therapeutics In | G Gift | 2019-12-19 | 2020-01-10 | 17,313 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | G Gift | 2019-12-19 | 2020-01-10 | 17,313 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-10 | 2019-12-11 | 10,000 | — | $0 | 396,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-10 | 2019-12-11 | 10,000 | $15.99 | $159.9K | 529,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-10 | 2019-12-11 | 10,000 | $4.75 | $47.5K | 539,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-09 | 2019-12-11 | 10,000 | — | $0 | 440,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-09 | 2019-12-11 | 10,000 | $4.75 | $47.5K | 741,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-09 | 2019-12-11 | 10,000 | $17.02 | $170.2K | 731,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-11-11 | 2019-11-12 | 10,000 | — | $0 | 406,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-11-11 | 2019-11-12 | 10,000 | $4.75 | $47.5K | 539,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-11-11 | 2019-11-12 | 10,000 | $14.76 | $147.6K | 529,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-11-08 | 2019-11-12 | 10,000 | — | $0 | 450,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-11-08 | 2019-11-12 | 10,000 | $14.63 | $146.3K | 731,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-11-08 | 2019-11-12 | 10,000 | $4.75 | $47.5K | 741,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-11-01 | 2019-11-05 | 10,000 | — | $0 | 460,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-11-01 | 2019-11-05 | 10,000 | — | $0 | 416,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-11-01 | 2019-11-05 | 10,000 | $4.75 | $47.5K | 539,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-11-01 | 2019-11-05 | 10,000 | $12.00 | $120.0K | 731,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-11-01 | 2019-11-05 | 10,000 | $12.00 | $120.0K | 529,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-11-01 | 2019-11-05 | 10,000 | $4.75 | $47.5K | 741,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-09-16 | 2019-09-17 | 10,000 | — | $0 | 426,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-09-16 | 2019-09-17 | 10,000 | — | $0 | 470,303 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-09-16 | 2019-09-17 | 10,000 | $4.75 | $47.5K | 539,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-09-16 | 2019-09-17 | 10,000 | $12.00 | $120.0K | 529,767 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-09-16 | 2019-09-17 | 10,000 | $4.75 | $47.5K | 741,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-09-16 | 2019-09-17 | 10,000 | $12.00 | $120.0K | 731,134 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 8,896 | — | $0 | 8,896 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2019-06-21 | 2019-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 87,200 | — | $0 | 87,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 231,200 | — | $0 | 231,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 231,200 | — | $0 | 231,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 87,200 | — | $0 | 87,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-01-07 | 2019-01-09 | 12,500 | — | $0 | 15,357 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-01-07 | 2019-01-09 | 12,500 | $10.23 | $127.9K | 731,134 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-01-07 | 2019-01-09 | 12,500 | $0.03 | $375 | 743,634 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-12-07 | 2018-12-10 | 12,500 | — | $0 | 27,857 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-12-07 | 2018-12-10 | 12,500 | $10.11 | $126.4K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-12-07 | 2018-12-10 | 12,500 | $0.03 | $375 | 726,010 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-11-26 | 2018-11-27 | 9,600 | — | $0 | 436,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-11-26 | 2018-11-27 | 9,600 | $4.75 | $45.6K | 521,743 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-11-26 | 2018-11-27 | 9,600 | $11.00 | $105.6K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-11-19 | 2018-11-21 | 400 | — | $0 | 445,661 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-11-19 | 2018-11-21 | 400 | $4.75 | $1.9K | 512,543 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-11-19 | 2018-11-21 | 400 | $11.14 | $4.5K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-11-07 | 2018-11-09 | 12,500 | — | $0 | 40,357 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-11-07 | 2018-11-09 | 12,500 | $0.03 | $375 | 726,010 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-11-07 | 2018-11-09 | 12,500 | $11.65 | $145.6K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-10-18 | 2018-10-22 | 10,000 | — | $0 | 446,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-10-18 | 2018-10-22 | 10,000 | $12.63 | $126.3K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-10-18 | 2018-10-22 | 10,000 | $4.75 | $47.5K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-10-08 | 2018-10-09 | 10,736 | — | $0 | 52,857 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-10-08 | 2018-10-09 | 1,764 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-10-08 | 2018-10-09 | 6,000 | $16.13 | $96.8K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-10-08 | 2018-10-09 | 1,764 | $0.03 | $53 | 715,274 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-10-08 | 2018-10-09 | 10,736 | $0.03 | $322 | 726,010 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-10-08 | 2018-10-09 | 6,500 | $15.39 | $100.0K | 719,510 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2018-09-28 | 2018-10-02 | 4,000 | — | $0 | 8,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2018-09-28 | 2018-10-02 | 4,000 | $7.49 | $30.0K | 4,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-09-18 | 2018-09-18 | 10,000 | — | $0 | 456,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-09-18 | 2018-09-18 | 10,000 | $18.26 | $182.6K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-09-18 | 2018-09-18 | 10,000 | $4.75 | $47.5K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-09-07 | 2018-09-10 | 12,500 | — | $0 | 1,764 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-09-07 | 2018-09-10 | 12,500 | $19.31 | $241.4K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-09-07 | 2018-09-10 | 12,500 | $0.03 | $375 | 726,010 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-08-20 | 2018-08-21 | 10,000 | — | $0 | 466,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-08-20 | 2018-08-21 | 10,000 | $4.75 | $47.5K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-08-20 | 2018-08-21 | 10,000 | $17.46 | $174.6K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-08-07 | 2018-08-08 | 12,500 | — | $0 | 14,264 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-08-07 | 2018-08-08 | 12,500 | $18.04 | $225.5K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-08-07 | 2018-08-08 | 12,500 | $0.03 | $375 | 726,010 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-07-18 | 2018-07-20 | 1 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-07-18 | 2018-07-20 | 5,757 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-07-18 | 2018-07-20 | 4,242 | — | $0 | 476,061 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-07-18 | 2018-07-20 | 10,000 | $18.27 | $182.7K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-07-18 | 2018-07-20 | 1 | $0.03 | $0 | 512,144 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-07-18 | 2018-07-20 | 5,757 | $0.26 | $1.5K | 517,901 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-07-18 | 2018-07-20 | 4,242 | $4.75 | $20.1K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-07-09 | 2018-07-10 | 12,500 | — | $0 | 26,764 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-07-09 | 2018-07-10 | 12,500 | $18.72 | $234.0K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-07-09 | 2018-07-10 | 12,500 | $0.03 | $375 | 726,010 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 10,516 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 10,516 | — | $0 | 63,690 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-06-18 | 2018-06-19 | 10,000 | — | $0 | 5,757 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-06-18 | 2018-06-19 | 10,000 | $18.66 | $186.6K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-06-18 | 2018-06-19 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2018-06-12 | 2018-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-06-07 | 2018-06-11 | 9,697 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-06-07 | 2018-06-11 | 303 | — | $0 | 7,553 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-06-07 | 2018-06-11 | 9,697 | $0.26 | $2.5K | 723,207 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-06-07 | 2018-06-11 | 10,000 | $17.30 | $173.0K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-06-07 | 2018-06-11 | 303 | $0.03 | $9 | 723,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-05-18 | 2018-05-21 | 10,000 | — | $0 | 15,757 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-05-18 | 2018-05-21 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-05-18 | 2018-05-21 | 10,000 | $19.39 | $193.9K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-05-07 | 2018-05-08 | 10,000 | — | $0 | 9,697 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-05-07 | 2018-05-08 | 10,000 | $16.77 | $167.7K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-05-07 | 2018-05-08 | 10,000 | $0.26 | $2.6K | 723,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-04-18 | 2018-04-20 | 7,576 | — | $0 | 18,181 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-04-18 | 2018-04-20 | 2,424 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-04-18 | 2018-04-20 | 10,000 | $14.79 | $147.9K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-04-18 | 2018-04-20 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-04-09 | 2018-04-10 | 10,000 | — | $0 | 19,697 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-04-09 | 2018-04-10 | 10,000 | $0.26 | $2.6K | 723,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-04-09 | 2018-04-10 | 10,000 | $12.48 | $124.8K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-03-19 | 2018-03-20 | 10,000 | — | $0 | 2,424 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-03-19 | 2018-03-20 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-03-19 | 2018-03-20 | 10,000 | $15.29 | $152.9K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-03-07 | 2018-03-08 | 606 | — | $0 | 29,697 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-03-07 | 2018-03-08 | 9,394 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-03-07 | 2018-03-08 | 10,000 | $16.15 | $161.5K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-03-07 | 2018-03-08 | 10,000 | $0.26 | $2.6K | 723,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-02-20 | 2018-02-22 | 10,000 | — | $0 | 12,424 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-20 | 2018-02-22 | 10,000 | $14.79 | $147.9K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-02-20 | 2018-02-22 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-02-07 | 2018-02-08 | 10,000 | — | $0 | 9,394 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-07 | 2018-02-08 | 10,000 | $12.50 | $125.0K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-02-07 | 2018-02-08 | 10,000 | $0.26 | $2.6K | 723,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-01-24 | 2018-01-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-01-24 | 2018-01-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-01-18 | 2018-01-22 | 10,000 | — | $0 | 22,424 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-01-18 | 2018-01-22 | 10,000 | $10.09 | $100.9K | 512,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-01-18 | 2018-01-22 | 10,000 | $0.26 | $2.6K | 522,143 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-01-08 | 2018-01-09 | 10,000 | — | $0 | 19,394 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-01-08 | 2018-01-09 | 10,000 | $10.08 | $100.8K | 713,510 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-01-08 | 2018-01-09 | 10,000 | $0.26 | $2.6K | 723,510 | SEC↗ |